Dr. Lal Pathlabs Ltd

NSE: LALPATHLAB · BSE: 539524 · Healthcare · 56 announcements

Share price: ₹1,945.10
Market cap: ₹32,648 Cr
Revenue (annual): ₹2,763 Cr
Net profit (annual): ₹504.8 Cr
P/E (TTM): 60.2×Sector 53.1×
Promoter holding: 53.19%-0.02% QoQ
FII holding: 17.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17 Jul 2026 19:48 IST NSE

Dr. Lal Pathlabs Legal & Regulatory

Dr. Lal Path Labs received a favorable Income Tax appellate order for FY 2021-22. The 32.66 Crore ESOP expense deduction was successfully allowed.

Value: ₹32.66 Cr

Read the filing ↗

17 Jul 2026 19:40 IST NSE

Legal & Regulatory

Dr. Lal Pathlabs Legal & Regulatory

Dr. Lal PathLabs received a favorable appellate order from the Income Tax Department. The order allows a tax deduction of Rs.32.66 Crore regarding ESOP expenses.

Value: ₹32.66 Cr

Read the filing ↗